A new study has found a surprising link between high levels of methylmalonic acid and the weakening of CD8+ T cells, shedding ...
News Medical on MSN1d
New molecular classification of gastrointestinal stromal tumors guides precision treatmentBGI Genomics and partners have published a transformative study in Nature Communications that links genetic differences in ...
News Medical on MSN9d
Intrinsic factors of the CAR-T cells may play a major role on its clinical successResearchers from the Josep Carreras Leukaemia Research Institute have found that the efficacy of varni-cel, a CAR-T infusion ...
StudyFinds on MSN13d
Repurposed cancer vaccine stops early-stage tumors from growing, study revealsRather than discarding a failed cancer treatment, scientists are getting a second chance to test this vaccine on newly ...
A new study has found a surprising link between high levels of methylmalonic acid and the weakening of CD8+ T cells, shedding ...
New study of ‘immune memory’ and T-cells has the goal of coming up with the next wave of immunotherapy, UCSD researcher says ...
31, 2024 — A new study has found a surprising link between high levels of methylmalonic acid and the weakening of CD8+ T cells ... promote lung cancer ... Oct. 30, 2024 — Cell division ...
AZoLifeSciences on MSN5d
New Discovery Shows TAGLN2 Protein Boosts T Cell Immunity Against Tumors by Enhancing Lipid MetabolismFindings indicate ovarian cancer disrupts CD8+ T cell metabolism through FABP5 and TAGLN2, suggesting new therapeutic targets ...
Researchers have uncovered a new pathway that enables cancer cells to grow unchecked by disabling the immune system.
Their study, published in Oncogene, explores how increased methylmalonic acid impairs the activation and effector functions of CD8+ T cells, immune cells that play a vital role in fighting cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback